| First Author | Takehara M | Year | 2017 |
| Journal | Biochem Biophys Res Commun | Volume | 487 |
| Issue | 2 | Pages | 419-425 |
| PubMed ID | 28419838 | Mgi Jnum | J:251359 |
| Mgi Id | MGI:6101638 | Doi | 10.1016/j.bbrc.2017.04.077 |
| Citation | Takehara M, et al. (2017) Peptidoglycan accelerates granulopoiesis through a TLR2- and MyD88-dependent pathway. Biochem Biophys Res Commun 487(2):419-425 |
| abstractText | Granulopoiesis is accelerated during Gram-negative bacterial infection through activation of toll-like receptor 4 (TLR4). In this study, we tested whether activation of TLR2 promotes granulopoiesis by using the well-known TLR2 agonist, peptidoglycan (PGN). Neutrophils in bone marrow and spleen, and plasma granulocyte colony-stimulating factor (G-CSF) were increased in mice that had received intraperitoneal PGN administration. Incorporation of BrdU into bone marrow neutrophils increased, demonstrating that PGN accelerated granulopoiesis. Treatment of bone marrow cells (BMCs) with PGN increased neutrophils in vitro and promoted the secretion of G-CSF from Ly-6G(-)Ly-6C(+) monocytes. The accelerated granulopoiesis caused by PGN was not seen in TLR2-deficient and MyD88-deficient BMCs. Additionally, PGN induced G-CSF production in human umbilical vein endothelial cells. These findings demonstrate that PGN promotes the secretion of G-CSF from monocytes and endothelial cells, leading to the acceleration of granulopoiesis. Our results illustrate that bacterial recognition by TLR2 facilitates granulopoiesis during Gram-positive bacterial infection. |
